Ilyang Pharm (007570) — Long-term Investment Intensity
Ilyang Pharm (007570) has a Long-term Investment Intensity of 0.8% as of December 2019. Long-term investments of ₩3.36 Billion represent 0.8% of total assets of ₩437.46 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See 007570 book value for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Ilyang Pharm Long-term Investment Intensity (2013–2019)
This chart shows how Ilyang Pharm's Long-term Investment Intensity has evolved across 7 annual periods from 2013 to 2019. As of December 2019, the intensity stands at 0.8%, reflecting long-term investments of ₩3.36 Billion against total assets of ₩437.46 Billion KRW. Also explore 007570 asset base for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Ilyang Pharm (2013–2019)
The table below presents the year-by-year Long-term Investment Intensity for Ilyang Pharm from 2013 to 2019, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Ilyang Pharm (007570) total market value.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 0.8% | ₩3.36 Billion | ₩437.46 Billion | ▼ -0.3 pp |
| 2018 | 1.0% | ₩4.47 Billion | ₩432.25 Billion | ▼ -0.1 pp |
| 2017 | 1.2% | ₩5.11 Billion | ₩436.37 Billion | ▲ +0.1 pp |
| 2016 | 1.1% | ₩4.56 Billion | ₩431.26 Billion | ▲ +0.2 pp |
| 2015 | 0.9% | ₩3.72 Billion | ₩431.63 Billion | ▲ +0.1 pp |
| 2014 | 0.8% | ₩3.44 Billion | ₩430.83 Billion | ▼ -2.1 pp |
| 2013 | 2.9% | ₩11.47 Billion | ₩398.38 Billion | — |